NCT07220486 Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
| NCT ID | NCT07220486 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Nursing Home Resident |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-11-05 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-11-05 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL) for skilled nursing facility residents and their primary support person. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. The researchers will compare the InSTILL program to minimally enhanced usual care. Participants will be randomly assigned to receive either the InSTILL program or minimally enhanced usual care. Participants will complete assessments at three timepoints (all) and a brief-exit interview.
Eligibility Criteria
Inclusion Criteria: * Patient and care partner both aged ≥ 18 years * Patient with care partner (known person providing regular health-related, socioemotional, or practical support) willing to participate * Patient reporting depression symptoms on a screening tool (Patient Health Questionnaire) Exclusion Criteria: * Patient intended length of nursing facility stay \< 7 days * Patient evidencing more than mild impairment on a cognitive screen (Brief Interview for Mental Status) * Patient's roommate in skilled nursing facility already enrolled in study/intervention * Either patient or care partner reporting high risk of suicidality, based on a standardized safety assessment tool * Either patient or care partner participating in newly initiated psychotherapy
Contact & Investigator
Evan Plys, PhD
PRINCIPAL INVESTIGATOR
Massachusetts General Hospital
Frequently Asked Questions
Who can join the NCT07220486 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nursing Home Resident. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07220486 currently recruiting?
Yes, NCT07220486 is actively recruiting participants. Contact the research team at brisk@mgb.org for enrollment information.
Where is the NCT07220486 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07220486 clinical trial?
NCT07220486 is sponsored by Massachusetts General Hospital. The principal investigator is Evan Plys, PhD at Massachusetts General Hospital. The trial plans to enroll 100 participants.